$0.86+0.01 (+1.16%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Lite Strategy (LITS) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~26.7%/yr (FY22→FY24), net margin 27.2%; free cash flow runs at −284% of net income. Check the accrual gap.
The four lines that matter · FY22–FY26
Revenue ($M)—
0.0
FY22→FY26CAGR —
Net income ($M)▼346.2%
−71.2
FY22→FY26CAGR —
Free cash flow ($M)—
—
no FY26 valueCAGR —
Diluted EPS▲13.8%
−2.06
no value for 2 of 5 yearsCAGR —
What the receipts whisper · what a headline number hides
Share count
+0.0%
34.6mn → 34.6mn diluted shares since FY26. Broadly flat, so EPS moves with net income rather than with the share count.
What the income statement says · FY22–FY26
Where every revenue dollar goes · FY26 ($K)
Margin trend · direction beats level Gross Operating Net
The receipt · income statement · FY22–FY26 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY26 | FY25 | FY24 | FY23 | FY22 | YoY | CAGR 22→26 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | — | 0.0 | 0.0 | 65,297.0 | 48,816.0 | 40,697.0 | — | — |
Cost of revenue | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Gross profit | — | 0.0 | 0.0 | 65,297.0 | 48,816.0 | 40,697.0 | — | — |
Research & development | 134.0 | 122.0 | 3,923.0 | 16,561.0 | 52,450.0 | 85,641.0 | ▼96.9% | −80.6% |
Selling, general & admin | 11,304.0 | 12,047.0 | 13,532.0 | 23,295.0 | 33,130.0 | 30,540.0 | ▼11.0% | −20.7% |
Total operating expenses | 48,317.0 | 66,577.0 | 17,455.0 | 50,755.0 | 85,580.0 | 116,181.0 | ▲281.4% | −13.0% |
Operating incomefeeds ROC rank | −48,317.0 | −66,577.0 | −17,455.0 | 14,542.0 | −36,764.0 | −75,484.0 | ▼281.4% | — |
Other income, net | −3,171.0 | −4,573.0 | 1,510.0 | 3,277.0 | 4,926.0 | 21,030.0 | — | — |
Pretax income | −51,488.0 | −71,150.0 | −15,945.0 | 17,819.0 | −31,838.0 | −54,454.0 | ▼346.2% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −51,488.0 | −71,150.0 | −15,945.0 | 17,778.0 | −31,838.0 | −54,454.0 | ▼346.2% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −1.46 | −2.06 | −2.39 | — | — | −9.99 | ▲13.8% | — |
Diluted shares (mn) | 33.18 | 34.56 | 6.66 | — | — | 6.26 | ▲418.7% | — |
| Margins | ||||||||
Gross margin | — | — | — | 100.0% | 100.0% | 100.0% | — | — |
Operating margin | — | — | — | 22.3% | −75.3% | −185.5% | — | — |
Net margin90th pct in Healthcare | — | — | — | 27.2% | −65.2% | −133.8% | — | — |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 11 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-09-28 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

